Free Trial

Avantor (NYSE:AVTR) Updates FY 2025 Earnings Guidance

Avantor logo with Medical background

Key Points

  • Avantor has updated its FY 2025 earnings guidance, projecting an EPS of 0.940-0.980, below the consensus estimate of 1.024.
  • The company's stock recently opened at $11.39 and has experienced a 1.8% increase on the trading day.
  • Analysts have mixed ratings on Avantor, with price targets ranging from $12.00 to $16.00, indicating a potential hold rather than a buy.
  • Looking to Export and Analyze Avantor Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Avantor (NYSE:AVTR - Get Free Report) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 0.940-0.980 for the period, compared to the consensus EPS estimate of 1.024. The company issued revenue guidance of -.

Avantor Trading Up 1.8%

Avantor stock opened at $11.39 on Friday. The firm has a market capitalization of $7.76 billion, a price-to-earnings ratio of 11.50, a P/E/G ratio of 1.26 and a beta of 0.96. The company has a current ratio of 0.98, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Avantor has a 12-month low of $10.82 and a 12-month high of $27.83. The firm has a 50 day moving average of $13.25 and a 200 day moving average of $15.19.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a net margin of 10.31% and a return on equity of 11.39%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the company earned $0.25 EPS. The business's revenue was down 1.1% compared to the same quarter last year. As a group, research analysts predict that Avantor will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on AVTR shares. Barclays reissued an "overweight" rating and set a $13.00 price target (down previously from $15.00) on shares of Avantor in a research report on Monday. The Goldman Sachs Group lowered shares of Avantor from a "buy" rating to a "neutral" rating and dropped their price target for the company from $23.00 to $14.00 in a research note on Tuesday, April 29th. Wells Fargo & Company lowered their target price on Avantor from $19.00 to $16.00 and set an "overweight" rating on the stock in a report on Monday. Jefferies Financial Group reissued a "hold" rating on shares of Avantor in a research report on Friday, August 1st. Finally, Stifel Nicolaus set a $12.00 price target on Avantor and gave the stock a "hold" rating in a research note on Monday. Eight analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $15.50.

View Our Latest Research Report on AVTR

Insider Activity

In other news, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. The trade was a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gregory L. Summe purchased 30,000 shares of the company's stock in a transaction that occurred on Friday, May 23rd. The stock was bought at an average cost of $12.50 per share, with a total value of $375,000.00. Following the purchase, the director owned 100,000 shares of the company's stock, valued at $1,250,000. This represents a 42.86% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Avantor

An institutional investor recently raised its position in Avantor stock. Empowered Funds LLC increased its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 40.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,659 shares of the company's stock after buying an additional 5,075 shares during the period. Empowered Funds LLC's holdings in Avantor were worth $286,000 at the end of the most recent quarter. Institutional investors own 95.08% of the company's stock.

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Earnings History and Estimates for Avantor (NYSE:AVTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines